New classes of potent heparanase inhibitors from ligand-based virtual screening
Heparanase is a validated target in cancer therapy and a potential target for several inflammatory pathologies. A ligand-based virtual screening of commercial libraries was performed to expand the chemical space of small-molecule inhibitors. The screening was based on similarity with known inhibitor...
Saved in:
Main Authors: | Daniele Pala (Author), Laura Scalvini (Author), Gian Marco Elisi (Author), Alessio Lodola (Author), Marco Mor (Author), Gilberto Spadoni (Author), Fabiana F. Ferrara (Author), Emiliano Pavoni (Author), Giuseppe Roscilli (Author), Ferdinando M. Milazzo (Author), Gianfranco Battistuzzi (Author), Silvia Rivara (Author), Giuseppe Giannini (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different roles for the acyl chain and the amine leaving group in the substrate selectivity of N-Acylethanolamine acid amidase
by: Andrea Ghidini, et al.
Published: (2021) -
Role of heparanase in pulmonary hypertension
by: Lin-Jun Wang, et al.
Published: (2023) -
Evaluation of Immunohistochemical Expression of Heparanase in -Associated Chronic Gastritis
by: Sheren Farrag Mahmoud Ahmed, et al.
Published: (2023) -
Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
by: Maria Aparecida Silva Pinhal, et al.
Published: (2016) -
Role of heparanase in ARDS through autophagy and exosome pathway (review)
by: Fei Feng, et al.
Published: (2023)